1. 2021
  2. Effect of three-day pretreatment of male rats with a thieno[2,3-d]pyrimidine-based allosteric agonist on the steroidogenic effects of human chorionic gonadotropin

    Stepochkina, A. M., Bakhtyukov, A. A., Derkach, K. V., Сорокоумов, В. Н., Дарьин, Д. В. & Shpakov, A. O., Jul 2021, In: FEBS Open Bio. 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  3. The Effect of Low-Molecular-Weight Allosteric Agonist of Luteinizing Hormone Receptor on Functional State of the Testes in Aging and Diabetic Rats

    Derkach, K. V., Romanova, I. V., Bakhtyukov, A. A., Morina, I. Y., Dar’in, D. V., Sorokoumov, V. N. & Shpakov, A. O., May 2021, In: Bulletin of Experimental Biology and Medicine. 171, 1, p. 81-86 6 p.

    Research output: Contribution to journalArticlepeer-review

  4. Effects of metformin and luteinizing hormone receptor agonists on steroidogenesis and spermatogenesis in rats with type 2 diabetes with their separate and combined administration

    Bakhtyukov, A. A., Derkach, K. V., Stepochkina, A. M., Sorokoumov, V. N., Bayunova, L. V., Lebedev, I. A. & Shpakov, A. O., 2021, 19th Annual World Congress “Insulin resistance, diabetes and cardiovascular disease”.

    Research output: Chapter in Book/Report/Conference proceedingConference abstractsResearchpeer-review

  5. THE DEVELOPMENT OF NEW THIENO[2,3-d]PYRIMIDINE DERIVATIVE WITH THE ACTIVITY OF ALLOSTERIC ANTAGONISTS OF THYROID-STIMULATING HORMONE (TSH) RECEPTOR

    Sorokoumov, V. N., Belysheva, M. N., Derkach, K. V., Bakhtyukov, A. A. & Shpakov, A. O., 2021, p. 633-634. 2 p.

    Research output: Contribution to conferencePaper

ID: 161479